Literature DB >> 10553072

Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines.

J H Kim1, B D Lee, Y Kim, S D Lee, P G Suh, S H Ryu.   

Abstract

Phospholipase D (PLD) has been implicated in a variety of cellular processes, including inflammation, secretion, and respiratory burst. Two distinct PLD isoforms, designated PLD1 and PLD2, have been cloned; however, the regulatory mechanism for each PLD isoform is not clear. In our present study we investigated how PLD2 activity is regulated in mouse lymphocytic leukemia L1210 cells, which mainly contain PLD2, and in PLD2 -transfected COS-7 cells. Intriguingly, A23187, a calcium ionophore that induces calcium influx, potently stimulates PLD activity in these two cell lines, suggesting that Ca2+ might be implicated in the regulation of the PLD2 activity. In addition to the A23187-induced PLD2 activation, A23187 also increases PLA2-mediated arachidonic acid release, and the A23187-stimulated PLD2 and PLA2 activities could be blocked by pretreatment of the cells with cytosolic calcium-dependent PLA2 (cPLA2) inhibitors, such as arachidonyl trifluoromethyl ketone and methyl arachidonyl fluorophosphonate in these two cell lines. Moreover, the A23187-induced PLD2 and PLA2 activities could be inhibited by cotransfection with antisense cPLA2 oligonucleotide. These results suggest a role for cPLA2 in the regulation of PLD2 activity in vivo. The inhibitory effect of arachidonyl trifluoromethyl ketone on the A23187-induced PLD2 activity could be recovered by addition of exogenous lysophosphatidylcholine. This study is the first to demonstrate that PLD2 activity is up-regulated by Ca2+ influx and that cPLA2 may play a key role in the Ca2+-dependent regulation of PLD2 through generation of lysophosphatidylcholine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  The impact of chronic stress on the rat brain lipidome.

Authors:  T G Oliveira; R B Chan; F V Bravo; A Miranda; R R Silva; B Zhou; F Marques; V Pinto; J J Cerqueira; G Di Paolo; N Sousa
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

2.  Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid.

Authors:  Tamotsu Tsukahara; Ryoko Tsukahara; Yuko Fujiwara; Junming Yue; Yunhui Cheng; Huazhang Guo; Alyssa Bolen; Chunxiang Zhang; Louisa Balazs; Fabio Re; Guangwei Du; Michael A Frohman; Daniel L Baker; Abby L Parrill; Ayako Uchiyama; Tetsuyuki Kobayashi; Kimiko Murakami-Murofushi; Gabor Tigyi
Journal:  Mol Cell       Date:  2010-08-13       Impact factor: 17.970

3.  Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.

Authors:  Tiago Gil Oliveira; Robin B Chan; Huasong Tian; Mikael Laredo; Guanghou Shui; Agnieszka Staniszewski; Hong Zhang; Lili Wang; Tae-Wan Kim; Karen E Duff; Markus R Wenk; Ottavio Arancio; Gilbert Di Paolo
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

4.  Lack of alpha-synuclein modulates microglial phenotype in vitro.

Authors:  Susan A Austin; Lalida Rojanathammanee; Mikhail Y Golovko; Eric J Murphy; Colin K Combs
Journal:  Neurochem Res       Date:  2011-03-08       Impact factor: 3.996

5.  Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase.

Authors:  Jennifer A Mietla; Dayanjan S Wijesinghe; L Alexis Hoeferlin; Michael D Shultz; Ramesh Natarajan; Alpha A Fowler; Charles E Chalfant
Journal:  J Lipid Res       Date:  2013-04-10       Impact factor: 5.922

Review 6.  Structure and regulation of human phospholipase D.

Authors:  Forrest Z Bowling; Michael A Frohman; Michael V Airola
Journal:  Adv Biol Regul       Date:  2021-01-03

7.  Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.

Authors:  D Martins-de-Souza; P C Guest; L W Harris; N Vanattou-Saifoudine; M J Webster; H Rahmoune; S Bahn
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.